LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Company News/Avalign Technologies Acquires Slice Manufacturing Studios
Company News

Avalign Technologies Acquires Slice Manufacturing Studios

March 18, 2021 2 min read Premium comments

Advertisement

Secondary#nextsteparthropedix#avaligntechnologies#slicemanufacturingstudios

Bannockburn, Illinois-based Avalign Technologies, Inc. has announced the acquisition of Slice Manufacturing Studios in Akron, Ohio. The newly-acquired company will be known as Avalign Additive | Slice Manufacturing Studios.

Avalign Technologies is comprised of two divisions, Avalign Orthopedics and Avalign Surgical. Avalign Orthopedics manufactures implants and instruments for orthopedic, spine, trauma, and sports medicine applications. Avalign Surgical sells surgical instruments to hospitals, distributors, and orthopedic equipment manufacturers.

Slice Manufacturing is a leading provider of additive manufacturing for 3D printing of metal components for orthopedic applications, along with advanced mill-turn manufacturing. This full-spectrum contract studio offers product development, prototyping, metal 3D printing, mechanical testing, final production, sterile cleaning, packaging in tray systems, and final boxing/labeling, departing with a finished product.

OTW spoke with Randy Theken, founder of Slice Manufacturing, about the acquisition. Theken explained, “Slice Manufacturing was a result of my NextStep Arthropedix orthopedics company struggling to find a partner for contract manufacturing that could produce our iNSitu Acetabular cup. There were only two Additive EBM (Electron Beam Melting) Arcam machines that existed in the U.S. at the time. We couldn’t find the right contract manufacturer, so through necessity we built our own manufacturing facility that stands second to none.”

Avalign CEO Jeff McCaulley said of the acquisition, “We are very excited to add Slice’s additive manufacturing, high tolerance subtractive manufacturing, and sterile packaging capabilities to complement our broad array of existing capabilities and offerings.”

McCaulley continued, “As a pioneer in additive manufacturing of metal implants and components, Slice has built a reputation for industry-best standards and processes. The addition of these capabilities and new capacity puts us at the forefront of what will be one of the fastest growing sub-segments in our space.”

Avalign Chairman Ernest Waaser added, “The addition of Slice enhances Avalign’s manufacturing services offerings as part of our continued focus on strategically investing in and expanding the capabilities that we offer our customer base.”

Joe Lah, Slice Manufacturing General Manager, said, “Slice is excited to become a part of Avalign Technologies. The company was founded in 2017 as a captive manufacturer to NextStep Arthropedix (“NextStep”), and we have since grown significantly with NextStep, as well as with other medical device OEM customers who understand our expertise in additive manufacturing, as well as the importance of combining downstream subtractive manufacturing and sterile packaging. Joining Avalign enables us to accelerate our growth as part of a leading orthopedic solutions platform.”

For OTW’s previous coverage on Slice Manufacturing, see “Autoclavable, Reusable Titanium 3D-printed N95 Respirator” and “Randy Theken’s New Company and Return to Orthopedics.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy